Cerebral Thrombectomy Devices Market
Cerebral Thrombectomy Devices Market By Product Type (Snares, Suction Devices, Rheolytic Devices, Enveloping Coils), By End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics) - Global Market Insights 2018 to 2026
Analysis of Cerebral Thrombectomy Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Introduction
Thrombectomy is the surgical removal of blood clots formed in blood vessels. The removal of blood clots from the blood vessels in the brain is known as cerebral thrombectomy and the devices used for the same are known as cerebral thrombectomy devices.
Blockage in blood vessels in the brain can be caused due to various reasons such as atheroma, an embolus or a thrombus of one or more arteries. A blood clot may lead to the draining or leakage of blood into the brain, if left untreated. More than 90% of strokes account for cerebral infarction in the United States.
According to the Centers for Disease Control and Prevention (CDC), around 130,000 Americans are killed by strokes every year. Cerebral infraction is an ischemic stroke that results in a lack of blood supply to the brain. The risk factors associated with cerebral infraction include diabetes, high blood pressure, tobacco smoking, hyperlipoproteinemia, atherosclerosis, obesity and hypercholesterolemia.
Cerebral Thrombectomy Devices Market: Drivers and Restraints
The global increase in the incidences of chronic inflammatory diseases is expected to contribute significantly to the cerebral thrombectomy devices market growth. The growing incidences of cerebral infarction, due to the increasing prevalence of diabetes, obesity and other related factors are expected to drive the growth of the cerebral thrombectomy devices market.
Sickle cell anemia is also associated with the rising incidences of blood clots in the blood vessels in the brain and thus, its growing prevalence directly contributes to the growth of the cerebral thrombectomy devices market.
The rising incidence rate of chronic kidney disease, which is one of the causative factors of cerebral venous thrombosis, is expected to fuel the cerebral thrombectomy devices market growth. Recent advancements in products in the cerebral thrombectomy devices market by manufacturers are expected to drive the growth of the market.
On the other hand, the high treatment cost associated with cerebral thrombectomy may hamper the growth potential of the cerebral thrombectomy devices market. Low awareness and availability of skilled professionals for cerebral thrombectomy may impede the cerebral thrombectomy devices market growth.
Cerebral Thrombectomy Devices Market: Overview
The rapidly increasing incidence rate of ischemic strokes is the major driver for the cerebral thrombectomy devices market. The global cerebral thrombectomy devices market, on the basis of product type, is expected to be dominated by the snare segment, owing to the higher adoption of these devices by healthcare professionals for cerebral thrombectomy.
On the basis of end user, the cerebral thrombectomy devices market is expected to be dominated by the hospitals segment, due to the higher patient footfall for treatment. Manufacturers in the cerebral thrombectomy devices market are focusing on manufacturing advanced products for better patient compliance and to make the procedure easier.
Cerebral Thrombectomy Devices Market: Regional Outlook
The global cerebral thrombectomy devices market is expected to be dominated by North America, due to the higher adoption of these devices and the number of surgical procedures being performed using cerebral thrombectomy devices. Europe is expected to be the second most lucrative cerebral thrombectomy devices market, due to the higher incidences of cerebral venous thrombosis.
Asia-Pacific is expected to be the fastest growing cerebral thrombectomy devices market due to rapidly improving healthcare infrastructure, coupled with the increasing penetration of cerebral thrombectomy devices and increasing availability of skilled professionals.
The Latin America cerebral thrombectomy devices market is expected to witness steady growth, due to the improving product penetration in the region. The Middle East and Africa cerebral thrombectomy devices market is expected to be the least lucrative market, due to the low treatment seeking rate and comparatively less developed healthcare infrastructure in major regions.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Cerebral Thrombectomy Devices Market: Market Participants
Examples of some of the market participants in the global cerebral thrombectomy devices market include Penumbra, Inc., Stryker Corporation, Boston Scientific Corporation, ev3 Inc., Angiotech, Chestnut Medical Technologies, Inc., Abbott, Concentric Medical, Inc., NexGen Medical Systems, Cordis, Possis Medical, Inc., EKOS Corporation, Terumo Corporation, Medtronic plc and others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, Rest of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Cerebral Thrombectomy Devices Market: Segmentation
The global cerebral thrombectomy devices market is segmented on the basis of product type, by end user and by region
On the basis of product type, the cerebral thrombectomy devices market has been segmented as:
- Snares
- Catheters with Balloons
- Suction Devices
- Rheolytic Devices
- Enveloping Coils
- Others
On the basis of end user, the cerebral thrombectomy devices market has been segmented as:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- FAQs -
A rising incidence of chronic inflammatory diseases is expected to boost the cerebral thrombectomy devices market.
The snare segment will contribute to most of the cerebral thrombectomy devices in the market.
Penumbra, Inc., Stryker Corporation, Boston Scientific Corporation, and ev3 Inc., dominate the market.